September 8, 2014
RESEARCH TRIANGLE PARK, N.C. - Wednesday, August 20th 2014 [ME NewsWire]
Morgan Stanley Global Healthcare Conference
(BUSINESS WIRE)-- Quintiles CEO Tom Pike will present at the Morgan Stanley Global Healthcare Conference on Monday, September 8, 2014 in New York City at the Grand Hyatt Hotel.
The Quintiles presentation will begin at 9:55 a.m. (EDT). Investors may access a live audio webcast of the presentation on the Quintiles’ Investor Relations website at www.quintiles.com/investors. An archived audio version of the presentation will be available later that day.
About Quintiles
Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 30,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s top-100 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.
Click here to subscribe to Mobile Alerts for Quintiles.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50927408&lang=en
Contacts
Quintiles
Phil Bridges, Media Relations, +1.919.998.1653 (office) or
+1.919.457.6347 (mobile)
phil.bridges@quintiles.com
Karl Deonanan, Investor Relations, +1.919.998.2789
InvestorRelations@quintiles.com
RESEARCH TRIANGLE PARK, N.C. - Wednesday, August 20th 2014 [ME NewsWire]
Morgan Stanley Global Healthcare Conference
(BUSINESS WIRE)-- Quintiles CEO Tom Pike will present at the Morgan Stanley Global Healthcare Conference on Monday, September 8, 2014 in New York City at the Grand Hyatt Hotel.
The Quintiles presentation will begin at 9:55 a.m. (EDT). Investors may access a live audio webcast of the presentation on the Quintiles’ Investor Relations website at www.quintiles.com/investors. An archived audio version of the presentation will be available later that day.
About Quintiles
Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 30,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s top-100 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.
Click here to subscribe to Mobile Alerts for Quintiles.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50927408&lang=en
Contacts
Quintiles
Phil Bridges, Media Relations, +1.919.998.1653 (office) or
+1.919.457.6347 (mobile)
phil.bridges@quintiles.com
Karl Deonanan, Investor Relations, +1.919.998.2789
InvestorRelations@quintiles.com